What is Ashwagandha (KSM-66)?
Ashwagandha (Withania somnifera) is an Ayurvedic root adaptogen used for over 3,000 years. KSM-66 is a proprietary full-spectrum root extract manufactured by Ixoreal Biomed (Hyderabad), standardised to ≥5% withanolides using a milk-based extraction process. It is the most clinically studied ashwagandha extract, with over 24 human RCTs conducted specifically on the KSM-66 formulation. [1]
The term "adaptogen" refers to compounds that help the body adapt to physical and psychological stress without causing dependency. The primary active constituents in ashwagandha are withanolides (steroidal lactones), alkaloids, and saponins. KSM-66's standardisation to ≥5% withanolides provides a consistent active fraction across batches. [2]
KSM-66 vs. generic ashwagandha
Most of the clinical evidence is on KSM-66 or Sensoril (the other major standardised extract). Generic ashwagandha root powder with no withanolide standardisation has unpredictable potency — active content can vary 10× between batches. When you see 'ashwagandha' on an Indian supplement with no extract specification, assume it is not the same as what was studied in the RCTs.
How ashwagandha works
The primary proposed mechanisms are: (1) reduction of cortisol through modulation of the HPA (hypothalamic-pituitary-adrenal) axis, (2) GABAergic activity of withanolides, contributing to anxiolytic effects, and (3) anti-inflammatory effects via NF-κB pathway modulation. The cortisol-lowering effect has been directly measured in RCTs using serum cortisol as the primary endpoint, providing mechanistic validation. [3]
Clinical evidence
| Study | Design | n | Key finding | Grade |
|---|---|---|---|---|
| Chandrasekhar et al. (2012) — Stress doi:10.4103/0253-7176.106022 | RCT, 60 days, KSM-66 | n=64 | 600 mg/day KSM-66 significantly reduced PSS stress scores (−44% vs −5.5% placebo), serum cortisol (−27.9% vs +7.9%), and anxiety on multiple validated scales. | A |
| Wankhede et al. (2015) — Muscle/Strength doi:10.1186/s12970-015-0104-9 | RCT, 8 wk, KSM-66 | n=57 | 600 mg/day KSM-66 + resistance training vs. placebo + training: significant greater gains in bench press (+46.1 vs +26.4 kg), leg extension, and muscle size. Testosterone: +15% vs +2.9%. | B |
| Raut et al. (2012) — Safety & tolerability doi:10.4103/0257-7941.107344 | RCT, dose escalation | n=18 | 750–1,250 mg/day ashwagandha root extract well-tolerated. No serious adverse events. Mild GI discomfort in small minority at higher doses. | B |
| Pratte et al. (2014) — Anxiety & cortisol doi:10.1089/acm.2014.0177 | RCT, 8 wk, high-concentration extract | n=98 | 300 mg BID (600 mg/day) significantly reduced anxiety (−56.5% on GAD-7 vs −30.5% placebo) and morning serum cortisol (−24% vs −7.9%). Confirms Chandrasekhar findings. | A |
Dosage & protocol
Evidence-based dosing
300–600 mg/day of KSM-66 extract (standardised ≥5% withanolides). Effects build over 4–8 weeks — this is not an acute supplement. Take with food to reduce GI discomfort. Can be taken once daily (morning or evening) or split into two doses. Allow at least 8 weeks before evaluating response.
India-specific context
The home of ashwagandha — but quality varies enormously
Ashwagandha (Withania somnifera) is native to India, Pakistan, and the Mediterranean. India is the world's largest producer and exporter of ashwagandha root. The presence of KSM-66 manufacturing in Hyderabad means that authentic KSM-66 is actually more available and often cheaper in India than in Western markets. However, the market is also flooded with unstandardised root powder sold as "ashwagandha" at 10–20% the price of a standardised extract — these products have unpredictable withanolide content. [4]
Third-party lab test data
Indian brand comparison
| Brand | Extract | ₹/600mg dose | Withanolide spec | Our take |
|---|---|---|---|---|
| AS-IT-IS KSM-66 Ashwagandha | KSM-66 | ₹16 | ≥5% (KSM-66 certified) | Best value KSM-66. Verified extract. Top pick. |
| Nutrabay KSM-66 | KSM-66 | ₹22 | ≥5% (KSM-66 certified) | Good quality, slightly higher price. Reliable option. |
| Himalaya Ashvagandha | Proprietary | ₹8 | ~1.5% withanolides | Trusted brand, pharmacy-available. Lower withanolide spec than KSM-66. Fine for general use. |
| Generic ashwagandha powder | Root powder | ₹2–5 | Unstandardised | Unpredictable potency. Cannot replicate RCT outcomes. Not recommended. |
Scoring rubric — full breakdown
1. Evidence quality
Good RCT base specifically for KSM-66. Chandrasekhar (2012) and Pratte (2014) are well-designed, well-powered studies with objective endpoints (serum cortisol). However, the total RCT volume is much smaller than creatine or omega-3, and most studies are 8–12 weeks with no long-term follow-up. Overall evidence tier: Moderate — strong for stress/cortisol reduction, moderate for athletic performance, emerging for cognition.
2. Dosage confidence
Reasonably well-established at 300–600 mg/day of standardised extract (≥5% withanolides). Both 300 mg BID and 600 mg once daily have been studied with similar outcomes. Deduction for the complete dose-response gap above 600 mg/day — no studies have tested whether 900 mg or 1,200 mg/day provides additional benefit.
3. India market fit
Strong fit. Ashwagandha is part of the Ayurvedic tradition — regulatory acceptance is seamless, consumer familiarity is high, and the primary manufacturer (KSM-66) is Indian. Price per dose with certified KSM-66 is affordable. The main challenge is consumer education to choose standardised extract over generic root powder.
4. Safety profile
Generally well-tolerated at 300–600 mg/day. GI discomfort in a minority. Caution for: pregnancy (traditional use as emmenagogue; avoid in pregnancy), thyroid conditions (may increase thyroid hormone levels — relevant for those on thyroid medication), and potentially sedating at higher doses for some users. No serious adverse events in published RCTs.
5. Label accuracy (tested)
The 28% mislabelling rate on withanolide content (Labdoor 2023) is concerning for the generic ashwagandha category. Brands using certified KSM-66 ingredient rate much better — KSM-66 comes with ingredient-level certification. Score applies to the verified KSM-66 segment; generic products would score 4–5/10.
References
- 1Singh N, et al. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011. doi:10.4314/ajtcam.v8i5S.9
- 2Pingali U, et al. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacognosy Res. 2014. doi:10.4103/0974-8490.129021
- 3Chandrasekhar K, et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012. doi:10.4103/0253-7176.106022
- 4Mishra LC, et al. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000. doi:10.5694/j.1326-5377.2000.tb125812.x